176 related articles for article (PubMed ID: 38645895)
61. Electronic cigarettes for smoking cessation.
Hartmann-Boyce J; McRobbie H; Lindson N; Bullen C; Begh R; Theodoulou A; Notley C; Rigotti NA; Turner T; Butler AR; Fanshawe TR; Hajek P
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010216. PubMed ID: 33913154
[TBL] [Abstract][Full Text] [Related]
62. Biomedical risk assessment as an aid for smoking cessation.
Bize R; Burnand B; Mueller Y; Cornuz J
Cochrane Database Syst Rev; 2005 Oct; (4):CD004705. PubMed ID: 16235375
[TBL] [Abstract][Full Text] [Related]
63. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.
Apollonio D; Philipps R; Bero L
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010274. PubMed ID: 27878808
[TBL] [Abstract][Full Text] [Related]
64. System change interventions for smoking cessation.
Thomas D; Abramson MJ; Bonevski B; George J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010742. PubMed ID: 28185257
[TBL] [Abstract][Full Text] [Related]
65. Effects of Electronic Nicotine Delivery Systems Substitution on Body Weight Status: Protocol for a Systematic Review and Meta-Analysis.
La Rosa GRM; Qureshi MA; Frittitta L; Anastasi E; Polosa R
JMIR Res Protoc; 2024 Mar; 13():e56324. PubMed ID: 38530329
[TBL] [Abstract][Full Text] [Related]
66. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
[TBL] [Abstract][Full Text] [Related]
67. Effectiveness and Safety Profile of Alternative Tobacco and Nicotine Products for Smoking Reduction and Cessation: A Systematic Review.
Zakiyah N; Purwadi FV; Insani WN; Abdulah R; Puspitasari IM; Barliana MI; Lesmana R; Amaliya A; Suwantika AA
J Multidiscip Healthc; 2021; 14():1955-1975. PubMed ID: 34326646
[TBL] [Abstract][Full Text] [Related]
68. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.
Shiffman S; West R; Gilbert D;
Nicotine Tob Res; 2004 Aug; 6(4):599-614. PubMed ID: 15370156
[TBL] [Abstract][Full Text] [Related]
69. Biomedical risk assessment as an aid for smoking cessation.
Bize R; Burnand B; Mueller Y; Rège-Walther M; Camain JY; Cornuz J
Cochrane Database Syst Rev; 2012 Dec; 12():CD004705. PubMed ID: 23235615
[TBL] [Abstract][Full Text] [Related]
70. Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness.
Collins SE; Nelson LA; Stanton J; Mayberry N; Ubay T; Taylor EM; Hoffmann G; Goldstein SC; Saxon AJ; Malone DK; Clifasefi SL; Okuyemi K;
Subst Abus; 2019; 40(2):229-239. PubMed ID: 30924732
[No Abstract] [Full Text] [Related]
71. Developing a toolkit for panel management: improving hypertension and smoking cessation outcomes in primary care at the VA.
Savarimuthu SM; Jensen AE; Schoenthaler A; Dembitzer A; Tenner C; Gillespie C; Schwartz MD; Sherman SE
BMC Fam Pract; 2013 Nov; 14():176. PubMed ID: 24261337
[TBL] [Abstract][Full Text] [Related]
72. Crush the Crave: Development and Formative Evaluation of a Smartphone App for Smoking Cessation.
Baskerville NB; Struik LL; Dash D
JMIR Mhealth Uhealth; 2018 Mar; 6(3):e52. PubMed ID: 29500157
[TBL] [Abstract][Full Text] [Related]
73. Applying anthropology to eliminate tobacco-related health disparities.
Goldade K; Burgess D; Olayinka A; Whembolua GL; Okuyemi KS
Nicotine Tob Res; 2012 Jun; 14(6):631-8. PubMed ID: 22271609
[TBL] [Abstract][Full Text] [Related]
74. Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers.
Beard E; McNeill A; Aveyard P; Fidler J; Michie S; West R
Tob Control; 2013 Mar; 22(2):118-22. PubMed ID: 22135165
[TBL] [Abstract][Full Text] [Related]
75. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
Parascandola M
Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
[TBL] [Abstract][Full Text] [Related]
76. Global trends in smoking cessation research from 2002 to 2021: A bibliometric and visual analysis.
Xu Y; Gu Z; Zhang Y; He M; Gerber BS; Sadasivam RS; Liu F; Wang Z
Prev Med Rep; 2022 Dec; 30():101991. PubMed ID: 36193091
[TBL] [Abstract][Full Text] [Related]
77. Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.
Fox B; Henwood T; Schaap L; Bruyère O; Reginster JY; Beaudart C; Buckinx F; Roberts H; Cooper C; Cherubini A; dellʼAquilla G; Maggio M; Volpato S
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):50-9. PubMed ID: 26571282
[TBL] [Abstract][Full Text] [Related]
78. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
Edwards S; Puljević C; Dean JA; Gilks C; Boyd MA; Baker P; Watts P; Howard C; Gartner CE
AIDS Behav; 2023 Feb; 27(2):618-627. PubMed ID: 35869375
[TBL] [Abstract][Full Text] [Related]
79. Workplace interventions for smoking cessation.
Moher M; Hey K; Lancaster T
Cochrane Database Syst Rev; 2003; (2):CD003440. PubMed ID: 12804467
[TBL] [Abstract][Full Text] [Related]
80. Incentives for smoking cessation.
Cahill K; Hartmann-Boyce J; Perera R
Cochrane Database Syst Rev; 2015 May; (5):CD004307. PubMed ID: 25983287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
